Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2-derived RNA replicons as safe and effective vaccines

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2516587122Source: DataRank Database

SARS-CoV-2-derived RNA replicons as safe and effective vaccines is a research paper published in Proceedings of the National Academy of Sciences (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.75)OA: hybridTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Iván Nombela ORCID,Diego Muñoz‐Santos ORCID,Mercedes Ruiz-Yuste,Ana Marchena-Pasero ORCID,María A. Rueda-Huélamo

Live enrichment

PubMed:40991433 PMC:PMC12501190 OpenAlex:https://openalex.org/W4414465617

Government of Spain

Grant: PID2022-140328OB-I00

Government of Spain

Grant: PID2019-107001RB-I00

Comunidad de Madrid

Grant: Y2020/BIO- 6576

European Commission

Grant: ISOLDA Project No. 848166-2

Foundation for the NIH

Grant: P01 AI060699

Government of Spain

Grant: FPU21/02704

Comunidad de Madrid

Grant: PIPF-2022/SAL-GL-24549

Government of Spain

Grant: PID2019-107001RB-I00UE

Government of Spain

Grant: PREP2022-0005777

National Institutes of Health

Grant: 5P01AI060699-10

Animal Core

European Commission

Grant: 848166

Improved Vaccination Strategies for Older Adults

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2516587122

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2516587122

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2516587122

journalhttps://doi.org/10.1073/pnas.2516587122

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40991433

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies0301 basic medicine03 medical and health sciencesAnimalsSARS-CoV-2COVID-19 VaccinesMiceCOVID-19HumansRepliconAntibodies, ViralMice, TransgenicRNA, ViralSpike Glycoprotein, CoronavirusFemaleAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAdministration, Intranasal

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 VaccinesAdministration, IntranasalAnimalsAntibodies, ViralFemaleHumansMice, TransgenicRepliconRNA, ViralMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

RepliconImmunizationAntibodyImmune systemGeneVirusDNA vaccinationRNAVaccineCoronavirusRNA repliconSars-cov-2COVID-19 VaccinesCOVID-19Mice, TransgenicBiological SciencesAntibodies, ViralAntibodies, NeutralizingMiceSpike Glycoprotein, CoronavirusAnimalsHumansRNA, ViralFemaleAngiotensin-Converting Enzyme 2Administration, Intranasal

SARS-CoV-2-derived RNA replicons as safe and effective vaccines

FAIR Checklist

Authors (24)

Funding (11 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)